A citation-based method for searching scientific literature

Omran Abu Aboud, Robert H Weiss. Clin Chem 2013
Times Cited: 60







List of co-cited articles
463 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
21

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
Arun Sreekumar, Laila M Poisson, Thekkelnaycke M Rajendiran, Amjad P Khan, Qi Cao, Jindan Yu, Bharathi Laxman, Rohit Mehra, Robert J Lonigro, Yong Li,[...]. Nature 2009
15


Metabolomics in the study of kidney diseases.
Robert H Weiss, Kyoungmi Kim. Nat Rev Nephrol 2011
163
11

Clinical applications of metabolomics in oncology: a review.
Jennifer L Spratlin, Natalie J Serkova, S Gail Eckhardt. Clin Cancer Res 2009
485
11

Applications of metabolomics in cancer research.
Kathleen A Vermeersch, Mark P Styczynski. J Carcinog 2013
64
11

On the origin of cancer cells.
O WARBURG. Science 1956
11

Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry.
Warwick B Dunn, David Broadhurst, Paul Begley, Eva Zelena, Sue Francis-McIntyre, Nadine Anderson, Marie Brown, Joshau D Knowles, Antony Halsall, John N Haselden,[...]. Nat Protoc 2011
10

Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.
Nagireddy Putluri, Ali Shojaie, Vihas T Vasu, Shaiju K Vareed, Srilatha Nalluri, Vasanta Putluri, Gagan Singh Thangjam, Katrin Panzitt, Christopher T Tallman, Charles Butler,[...]. Cancer Res 2011
130
10

Metabolomics: beyond biomarkers and towards mechanisms.
Caroline H Johnson, Julijana Ivanisevic, Gary Siuzdak. Nat Rev Mol Cell Biol 2016
945
10

Distinct urinary metabolic profile of human colorectal cancer.
Yu Cheng, Guoxiang Xie, Tianlu Chen, Yunping Qiu, Xia Zou, Minhua Zheng, Binbin Tan, Bo Feng, Taotao Dong, Pingang He,[...]. J Proteome Res 2012
140
10

Metabolomics: building on a century of biochemistry to guide human health.
J Bruce German, Bruce D Hammock, Steven M Watkins. Metabolomics 2005
185
8

Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis.
Sheila Ganti, Sandra L Taylor, Omran Abu Aboud, Joy Yang, Christopher Evans, Michael V Osier, Danny C Alexander, Kyoungmi Kim, Robert H Weiss. Cancer Res 2012
83
8

Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness.
Guro F Giskeødegård, Helena Bertilsson, Kirsten M Selnæs, Alan J Wright, Tone F Bathen, Trond Viset, Jostein Halgunset, Anders Angelsen, Ingrid S Gribbestad, May-Britt Tessem. PLoS One 2013
118
8

Metabolomic signatures of aggressive prostate cancer.
Jonathan E McDunn, Zhen Li, Klaus-Peter Adam, Bruce P Neri, Robert L Wolfert, Michael V Milburn, Yair Lotan, Thomas M Wheeler. Prostate 2013
94
8


Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry.
Kishore Kumar Pasikanti, Kesavan Esuvaranathan, Yanjun Hong, Paul C Ho, Ratha Mahendran, Lata Raman Nee Mani, Edmund Chiong, Eric Chun Yong Chan. J Proteome Res 2013
72
8

Metabolic phenotyping in health and disease.
Elaine Holmes, Ian D Wilson, Jeremy K Nicholson. Cell 2008
486
8

Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach.
Juliana Vieira Alberice, Andre F S Amaral, Emily Grace Armitage, José Antonio Lorente, Ferrán Algaba, Emanuel Carrilho, Mirari Márquez, Antonia García, Núria Malats, Coral Barbas. J Chromatogr A 2013
84
8

HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease.
Pratima Tripathi, Bagganahalli S Somashekar, M Ponnusamy, Amy Gursky, Stephen Dailey, Priya Kunju, Cheryl T Lee, Arul M Chinnaiyan, Thekkelnaycke M Rajendiran, Ayyalusamy Ramamoorthy. J Proteome Res 2013
41
12

MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data.
Tomás Pluskal, Sandra Castillo, Alejandro Villar-Briones, Matej Oresic. BMC Bioinformatics 2010
8

A metabolomic approach to lung cancer.
Suya Hori, Shin Nishiumi, Kazuyuki Kobayashi, Masakazu Shinohara, Yukihisa Hatakeyama, Yoshikazu Kotani, Naoya Hatano, Yoshimasa Maniwa, Wataru Nishio, Takeshi Bamba,[...]. Lung Cancer 2011
141
8

Bladder cancer biomarker discovery using global metabolomic profiling of urine.
Bryan M Wittmann, Steven M Stirdivant, Matthew W Mitchell, Jacob E Wulff, Jonathan E McDunn, Zhen Li, Aphrihl Dennis-Barrie, Bruce P Neri, Michael V Milburn, Yair Lotan,[...]. PLoS One 2014
74
8

Diagnosis of bladder cancer and prediction of survival by urinary metabolomics.
Xing Jin, Seok Joong Yun, Pildu Jeong, Isaac Yi Kim, Wun-Jae Kim, Sunghyouk Park. Oncotarget 2014
98
8

Noninvasive urinary metabonomic diagnosis of human bladder cancer.
Kishore Kumar Pasikanti, Kesavan Esuvaranathan, Paul C Ho, Ratha Mahendran, Revathi Kamaraj, Qing Hui Wu, Edmund Chiong, Eric Chun Yong Chan. J Proteome Res 2010
130
8

Low- and high-grade bladder cancer determination via human serum-based metabolomics approach.
Navneeta Bansal, Ashish Gupta, Nilay Mitash, Prashant Singh Shakya, Anil Mandhani, Abbas Ali Mahdi, Satya Narain Sankhwar, Sudhir Kumar Mandal. J Proteome Res 2013
44
11

The progression from a lower to a higher invasive stage of bladder cancer is associated with severe alterations in glucose and pyruvate metabolism.
Vanessa R Conde, Pedro F Oliveira, Ana R Nunes, Cátia S Rocha, Elsa Ramalhosa, José A Pereira, Marco G Alves, Branca M Silva. Exp Cell Res 2015
54
9

Cell culture metabolomics: applications and future directions.
Miroslava Cuperlović-Culf, David A Barnett, Adrian S Culf, Ian Chute. Drug Discov Today 2010
134
8

Plasma free amino acid profiling of five types of cancer patients and its application for early detection.
Yohei Miyagi, Masahiko Higashiyama, Akira Gochi, Makoto Akaike, Takashi Ishikawa, Takeshi Miura, Nobuhiro Saruki, Etsuro Bando, Hideki Kimura, Fumio Imamura,[...]. PLoS One 2011
270
8

Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours.
Florian Jentzmik, Carsten Stephan, Kurt Miller, Mark Schrader, Andreas Erbersdobler, Glen Kristiansen, Michael Lein, Klaus Jung. Eur Urol 2010
161
8


Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer.
Guangguo Tan, Haibo Wang, Jianlin Yuan, Weijun Qin, Xin Dong, Hong Wu, Ping Meng. Sci Rep 2017
24
20

Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems.
Daniela Rodrigues, Carmen Jerónimo, Rui Henrique, Luís Belo, Maria de Lourdes Bastos, Paula Guedes de Pinho, Márcia Carvalho. Int J Cancer 2016
45
11

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
8

Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer.
Shan Zha, Sacha Ferdinandusse, Jessica L Hicks, Simone Denis, Thomas A Dunn, Ronald J Wanders, Jun Luo, Angelo M De Marzo, William B Isaacs. Prostate 2005
122
6

Metabolomics in cancer: a bench-to-bedside intersection.
Wederson M Claudino, Priscila H Goncalves, Angelo di Leo, Philip A Philip, Fazlul H Sarkar. Crit Rev Oncol Hematol 2012
54
7

Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells.
Shahriar Koochekpour, Sunipa Majumdar, Gissou Azabdaftari, Kristopher Attwood, Ray Scioneaux, Dhatchayini Subramani, Charles Manhardt, Giovanni D Lorusso, Stacey S Willard, Hillary Thompson,[...]. Clin Cancer Res 2012
88
6


Serum methionine metabolites are risk factors for metastatic prostate cancer progression.
Sally Stabler, Tatsuki Koyama, Zhiguo Zhao, Magaly Martinez-Ferrer, Robert H Allen, Zigmund Luka, Lioudmila V Loukachevitch, Peter E Clark, Conrad Wagner, Neil A Bhowmick. PLoS One 2011
61
6

Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles.
Carolyn M Slupsky, Kathryn N Rankin, James Wagner, Hao Fu, David Chang, Aalim M Weljie, Erik J Saude, Bruce Lix, Darryl J Adamko, Sirish Shah,[...]. Anal Chem 2007
269
6

Pharmaco-metabonomic phenotyping and personalized drug treatment.
T Andrew Clayton, John C Lindon, Olivier Cloarec, Henrik Antti, Claude Charuel, Gilles Hanton, Jean-Pierre Provost, Jean-Loïc Le Net, David Baker, Rosalind J Walley,[...]. Nature 2006
554
6

Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer.
Kyoungmi Kim, Sandra L Taylor, Sheila Ganti, Lining Guo, Michael V Osier, Robert H Weiss. OMICS 2011
101
6

Metabolomics analysis for biomarker discovery: advances and challenges.
M S Monteiro, M Carvalho, M L Bastos, P Guedes de Pinho. Curr Med Chem 2013
141
6


Preanalytical aspects and sample quality assessment in metabolomics studies of human blood.
Peiyuan Yin, Andreas Peter, Holger Franken, Xinjie Zhao, Sabine S Neukamm, Lars Rosenbaum, Marianna Lucio, Andreas Zell, Hans-Ulrich Häring, Guowang Xu,[...]. Clin Chem 2013
163
6

Human plasma stability during handling and storage: impact on NMR metabolomics.
Joana Pinto, M Rosário M Domingues, Eulália Galhano, Cristina Pita, Maria do Céu Almeida, Isabel M Carreira, Ana M Gil. Analyst 2014
100
6

Metabolomics: a global biochemical approach to drug response and disease.
Rima Kaddurah-Daouk, Bruce S Kristal, Richard M Weinshilboum. Annu Rev Pharmacol Toxicol 2008
441
6

Multiple myeloma patients have a specific serum metabolomic profile that changes after achieving complete remission.
Leonor Puchades-Carrasco, Ramón Lecumberri, Joaquín Martínez-López, Juan-José Lahuerta, María-Victoria Mateos, Felipe Prósper, Jesús F San-Miguel, Antonio Pineda-Lucena. Clin Cancer Res 2013
51
7

Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study.
Jun Maeda, Masahiko Higashiyama, Akira Imaizumi, Tomio Nakayama, Hiroshi Yamamoto, Takashi Daimon, Minoru Yamakado, Fumio Imamura, Ken Kodama. BMC Cancer 2010
96
6

A novel serum metabolomics-based diagnostic approach for colorectal cancer.
Shin Nishiumi, Takashi Kobayashi, Atsuki Ikeda, Tomoo Yoshie, Megumi Kibi, Yoshihiro Izumi, Tatsuya Okuno, Nobuhide Hayashi, Seiji Kawano, Tadaomi Takenawa,[...]. PLoS One 2012
172
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.